NOV 17, 2017 01:38 PM PST

Better Tool to Assess Spinal Muscular Atrophy Created

WRITTEN BY: Carmen Leitch

A new tool has been developed by Canon BioMedical that aims to improve the assessment of a devastating disease, spinal muscular atrophy (SMA), and may help create better therapeutics. SMA is an inherited disorder that can make it difficult for children to move; nerve cells waste away, leading to muscle loss. Defects in a gene called SMN1 lead to the illness, which has many varying degrees of severity.

A PCR-based assay created by Canon aims to improve the assessment of SMA / Image credit: Pixabay

Another gene, SMN2, can have a big impact on how serious the disease becomes in individuals. People that carry mutations in the SMN1 gene often have several copies of the SMN2 gene, which can make up for the loss of function caused by a defective SMN1 gene. Some affected individuals carry four normal copies of SMN2, making their conditions less serious. Determining copy number is thus an essential part of understanding individual cases. 

Usually, it takes special equipment and expensive reagents to assess copy number variation in the SMN1 and SMN2 genes. Testing conditions are also not conducive to studying a large number of samples. A method created by Canon Biomedical meets these challenges. Their simple technique, based on PCR, only requires a thermocycler that can perform high-resolution melting (HRM) in replicates. These Novallele copy number assays have been tested for use on a variety of instruments with various methods of DNA extraction, and have streamlined the whole process. It can take as little as one hour to complete it.

‘‘Our research and development team worked really hard to make sure our new copy number assays perform consistently and reliably for our customers. This isn’t an easy analysis to perform, but we developed a solution that is simple, fast, and accurate,” said Dennis Snyder, Senior Director of Global Commercial Operations for Canon BioMedical. ‘‘We hope our copy number assays for the SMN1 and SMN2 genes will help researchers understand spinal muscular atrophy and advance treatment for this terrible disease.’’

In the video above, Dr. Charlotte Sumner of Johns Hopkins University explains how the SMN2 copy number affects SMA. 

Source: Canon BioMedical, Muscular Dystrophy Association

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 11, 2019
Cell & Molecular Biology
NOV 11, 2019
A New Type of Biofluorescence is Described
There are living creatures that can absorb and reemit light, and its a widespread characteristic among marine animals....
NOV 11, 2019
Microbiology
NOV 11, 2019
Electric Bacteria Form Undersea Networks of Conductivity
A team of scientists has found that bacteria can act like power lines, and send electrical currents over long distances....
NOV 11, 2019
Genetics & Genomics
NOV 11, 2019
A More Precise Version of CRISPR/Cas9 is Created
A more accurate version of Cas9 has been created, reducing the number of off-target effects. It may be better suited for use in gene therapy....
NOV 11, 2019
Genetics & Genomics
NOV 11, 2019
A Cancer-Promoting Mutation is Found in 'Junk' DNA
A huge amount of our genome does not code for protein, but it can impact physiology in other ways....
NOV 11, 2019
Cell & Molecular Biology
NOV 11, 2019
Different Types of Cells Found in Male and Female Mouse Brains
A team of scientists has discovered rare cells in the brains of mice; one set is only found in males and another set is found only in females....
NOV 11, 2019
Cell & Molecular Biology
NOV 11, 2019
Rapamycin Can Prevent Age-related Memory Problems and Loss of Cerebral Blood Flow
Scientists have found that a drug called rapamycin can help restore blood flow to the brain that is lost during aging....
Loading Comments...